Skip to main content
. 2022 May 31;37(23):e180. doi: 10.3346/jkms.2022.37.e180

Fig. 3. Adverse effects after COVID-19 vaccination.

Fig. 3

(A) Comparison between healthy people and patients with ESRD on hemodialysis. (B) Comparison between patients with ESRD on hemodialysis who received ChAdOx1–BNT162b2 and those who received two doses of ChAdOx1.

COVID-19 = coronavirus disease 2019, ESRD = end-stage renal disease.

aP value <0.05.